Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about ABBV
Recent news which mentions ABBV
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
32
33
Next >
In-Depth Examination Of 11 Analyst Recommendations For AbbVie
October 07, 2024
Tickers
ABBV
Tags
ABBV
Benzinga
Analyst Ratings
From
Benzinga
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
October 07, 2024
Tickers
ABBV
CSLLY
GILD
GSK
Tags
Benzinga
Analyst Ratings
ABBV
From
Benzinga
3 Magnificent Dividend Stocks to Buy in October
October 06, 2024
Tickers
ABBV
ABT
AMGN
PFE
Tags
ABT
PFE
Market News
From
Motley Fool
Billionaires Are Loading Up on This High-Yield Dividend Stock. Should You?
October 06, 2024
Tickers
ABBV
Tags
Market News
ABBV
Recent Press Releases
From
Motley Fool
2 Top Dividend Stocks Yielding 3% or More to Buy Without Hesitation Right Now
October 05, 2024
Tickers
ABBV
KHC
Tags
Market News
KHC
ABBV
From
Motley Fool
Blue Shield of California Slashes Humira Biosimilar Prices in Landmark Deal
October 03, 2024
Tickers
ABBV
NEWS
UNH
Tags
Benzinga
Top Stories
UNH
From
Benzinga
Comparing AbbVie With Industry Competitors In Biotechnology Industry
October 03, 2024
Tickers
ABBV
NEWS
Tags
ABBV
Market News
Markets
From
Benzinga
Behind the Scenes of AbbVie's Latest Options Trends
October 03, 2024
Tickers
ABBV
Tags
Benzinga
BZI/UOA
ABBV
From
Benzinga
Medicare Drug Price Negotiation Program Gets Final Guidance For Second Cycle, $1.5B Savings Expected
October 03, 2024
Tickers
ABBV
GSK
NEWS
NVO
Tags
General
Top Stories
Benzinga
From
Benzinga
5 Best Dividend Growth Stocks to Buy in October
October 02, 2024
Tickers
ABBV
AXP
BAC
COST
Tags
Recent Press Releases
ABBV
Market News
From
Motley Fool
Meta, Accenture, Disney And A Major Health Care Stock On CNBC's 'Final Trades'
September 30, 2024
Tickers
ABBV
ACN
DIS
META
Tags
ABBV
Brenda Vingiello
Halftime Report Final Trades
From
Benzinga
(ABBV) - Analyzing AbbVie's Short Interest
September 27, 2024
Tickers
ABBV
Tags
Benzinga
Short Sellers
Short Ideas
From
Benzinga
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
September 27, 2024
Tickers
ABBV
BMY
NEWS
Tags
Top Stories
Benzinga
General
From
Benzinga
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
September 26, 2024
Tickers
ABBV
NEWS
Tags
News
Trading Ideas
Benzinga
From
Benzinga
AbbVie Says Pivotal Trial For Parkinson's Candidate Meets Its Primary Goal In Patients With Early Disease
September 26, 2024
Tickers
ABBV
NEWS
Tags
Benzinga
Top Stories
Health Care
From
Benzinga
Forget Novo Nordisk, Buy This Magnificent Dividend Stock Instead
September 26, 2024
Tickers
ABBV
NVO
Tags
ABBV
Recent Press Releases
NVO
From
Motley Fool
Behind the Scenes of AbbVie's Latest Options Trends
September 24, 2024
Tickers
ABBV
Tags
BZI/UOA
Benzinga
Market News
From
Benzinga
Bristol-Myers Acquired Drug KarXT Poised For FDA Approval As First New Type Of Schizophrenia Treatment In 70 Years
September 20, 2024
Tickers
ABBV
BMY
NEWS
Tags
Top Stories
Benzinga
Health Care
From
Benzinga
Spotlight on AbbVie: Analyzing the Surge in Options Activity
September 20, 2024
Tickers
ABBV
Tags
Market News
Markets
Options
From
Benzinga
Competitor Analysis: Evaluating AbbVie And Competitors In Biotechnology Industry
September 19, 2024
Tickers
ABBV
NEWS
Tags
News
Trading Ideas
Benzinga
From
Benzinga
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.